ACLS Provider: Course

Incorrect. Adenosine is administered as a rapid IV push at an initial dose of 6 mg to terminate stable SVT.

Incorrect. Atropine is the first-line drug for symptomatic bradycardia, increasing heart rate by blocking vagal stimulation.

Incorrect. Pediatric defibrillation starts at 2 J/kg and may increase to 4 J/kg for subsequent shocks if VF persists.

Incorrect. Naloxone is used to reverse opioid overdose, restoring respiratory effort in patients with respiratory depression.

Incorrect. Immediate CPR is required as asystole is a non-shockable rhythm.

Incorrect. The compression-to-ventilation ratio for single-rescuer infant CPR is 30:2, ensuring sufficient oxygenation and circulation.

Incorrect. Asystole is a non-shockable rhythm requiring high-quality CPR and epinephrine administration.

Incorrect. Ventricular fibrillation presents as a disorganized rhythm that requires immediate defibrillation.

Incorrect. PETCO2 monitoring helps assess the effectiveness of both ventilation and chest compressions in real-time during CPR.

Incorrect. Oxygen saturation should be maintained at 92-96% to prevent hypoxia and avoid the harmful effects of hyperoxia.

Incorrect. Adenosine is used to terminate reentrant arrhythmias in narrow-complex SVT by slowing conduction through the AV node.

Incorrect. Naloxone reverses opioid-induced respiratory depression, restoring normal respiratory function.

Incorrect. Delivers an electrical shock to depolarize the heart and restore a normal rhythm.

Incorrect. Oxygenation and ventilation should be optimized to avoid hypoxia or hyperoxia during post-cardiac arrest care.

Incorrect. Pulseless VT is treated with defibrillation, while synchronized cardioversion is reserved for tachyarrhythmias with a pulse.

Incorrect. Rotating team roles every 2 minutes prevents fatigue, ensuring consistent delivery of high-quality chest compressions.

Incorrect. A compression fraction >80% is required to maximize perfusion and improve survival rates during high-quality CPR.

Incorrect. Maintains vasoconstriction, improving blood flow to vital organs during resuscitation.

Incorrect. The correct compression-to-ventilation ratio for adult CPR without an advanced airway is 30:2.

Incorrect. The jaw-thrust avoids neck movement, making it the preferred airway technique for patients with suspected cervical spine injuries.

Incorrect. PEA is not a shockable rhythm; it is treated with CPR and addressing reversible causes such as hypoxia or hypovolemia.

Incorrect. Atropine is the first-line treatment for symptomatic bradycardia, increasing the heart rate by blocking vagal stimulation.

Incorrect. Requires immediate defibrillation to restore organized cardiac activity.

Incorrect. Amiodarone is preferred, but lidocaine is an alternative antiarrhythmic for refractory VF or pulseless VT.

Incorrect. High-quality CPR is the primary intervention for PEA, followed by epinephrine administration and addressing reversible causes.

Incorrect. For biphasic defibrillators, 120-200 J is the recommended energy range for VF.

Incorrect. VF is a shockable rhythm requiring immediate defibrillation to restore organized cardiac activity.

Incorrect. Amiodarone 300 mg IV/IO is administered after defibrillation and epinephrine to treat refractory VF or pulseless VT.

Incorrect. Magnesium sulfate is the first-line treatment for torsades de pointes as it stabilizes the myocardium.

Incorrect. With an advanced airway, compressions continue uninterrupted while ventilation is provided at a rate of 10 breaths per minute.

Incorrect. Prompt defibrillation within 30 seconds of witnessed VF arrest improves the chance of restoring a perfusing rhythm.

Incorrect. Positioning the patient with a slight left tilt prevents aortocaval compression and improves venous return during CPR.

Incorrect. A left lateral tilt prevents aortocaval compression, improving venous return and cardiac output during resuscitation.

Incorrect. Hypoxia is a reversible cause of PEA; it must be treated immediately with oxygenation and ventilation.

Incorrect. Synchronized cardioversion at 100 J is effective for restoring a stable rhythm in unstable ventricular tachycardia.

Incorrect. Defibrillation is the priority for VF and should not be delayed for drug administration, as it is the definitive treatment.

Incorrect. Hypovolemia is a reversible cause of cardiac arrest that can be treated with fluid resuscitation to restore circulation.

Incorrect. Rescuers should switch roles every 2 minutes to maintain high-quality chest compressions and prevent fatigue.

Incorrect. A PETCO2 level greater than 10 mmHg indicates that chest compressions are generating adequate blood flow.

Incorrect. Amiodarone is used after defibrillation and epinephrine for refractory VF to stabilize the myocardium.

Incorrect. Optimal for maintaining adequate circulation without risking poor perfusion due to excessive speed.

Incorrect. Pulseless VT is a shockable rhythm requiring immediate defibrillation to restore organized cardiac activity.

Incorrect. Thrombosis (pulmonary or coronary) is a reversible cause of cardiac arrest and should be addressed immediately.

Incorrect. Calling for help ensures timely assistance and access to advanced resuscitation equipment.

Incorrect. Maintaining a compression fraction of greater than 80% ensures the majority of resuscitation time is spent on compressions.

Incorrect. Lidocaine is an antiarrhythmic drug used as an alternative to amiodarone for VF or pulseless VT.

Incorrect. Post-ROSC care focuses on optimizing oxygenation, ventilation, and hemodynamic stability to prevent further organ damage.

Incorrect. Administered via rapid IV push, followed by a saline flush to terminate reentrant arrhythmias.

Incorrect. Epinephrine at 0.01 mg/kg is administered every 3-5 minutes during pediatric cardiac arrest to improve coronary perfusion.

Incorrect. Hypothermia is a reversible cause of cardiac arrest and is treated by warming the patient to improve outcomes.

Incorrect. Epinephrine is given every 3-5 minutes to enhance coronary and cerebral perfusion during cardiac arrest.

Incorrect. This rate ensures effective circulation without causing inadequate ventricular filling.

Incorrect. Providing 6-8 breaths per minute ensures adequate oxygenation and ventilation without interfering with chest compressions.

Incorrect. Atropine is the first-line drug for treating symptomatic bradycardia by increasing heart rate through vagal inhibition.

Incorrect. Providing 6-8 breaths per minute prevents hyperventilation and maintains adequate oxygenation during CPR with an advanced airway.

Incorrect. Pausing compressions for more than 10 seconds interrupts perfusion and reduces the chances of ROSC.

Incorrect. Epinephrine at 1 mg IV every 3-5 minutes is used to enhance perfusion during cardiac arrest.

Incorrect. CPR is the primary treatment for PEA, along with epinephrine and addressing reversible causes to restore circulation.

Incorrect. PEA is not treated with adenosine; it is managed with CPR, epinephrine, and identifying and treating reversible causes.

Incorrect. Defibrillation is the primary treatment for pulseless VT, aiming to restore organized cardiac activity.

Incorrect. Chest compressions are performed to dislodge the obstruction and restore effective ventilation in an unresponsive infant.

Incorrect. Rhythm checks should be performed every 2 minutes, coinciding with rescuer role switches, to evaluate for shockable rhythms.

Incorrect. A PETCO2 reading above 10 mmHg indicates that chest compressions are generating sufficient circulation during CPR.

Incorrect. Pediatric defibrillation starts at 2 J/kg for the initial shock, increasing as needed based on the patient's response.

Incorrect. Magnesium sulfate is administered to stabilize the myocardium and treat torsades de pointes effectively.